The Oncogenic Potential of Epstein-Barr Virus Nuclear Antigen 1 in Transgenic Mice
- 1 January 1992
- book chapter
- Published by Springer Nature
- Vol. 182, 375-384
- https://doi.org/10.1007/978-3-642-77633-5_48
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6Cell, 1990
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance regionCell, 1985
- Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodiesVirology, 1985
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.Proceedings of the National Academy of Sciences, 1984
- A comparison of epstein‐barr virus‐specific T‐cell immunity in malaria‐endemic and ‐nonendemic regions of Papua New GuineaInternational Journal of Cancer, 1983
- Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and menCell, 1983